← Open Payments lookup

MELISSA SHARP: Open Payments

NPI 1336837210 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,216 in 34 payments from 14 companies in 2025. Trend: 2023 $13 · 2024 $1,069 · 2025 $1,216

Food & beverage: $1,216
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$255
ABBVIE INC.7$193
Janssen Pharmaceuticals, Inc2$152
Otsuka America Pharmaceutical, Inc.3$144
Vanda Pharmaceuticals Inc.2$128
Alkermes, Inc.1$122
Teva Pharmaceuticals USA, Inc.2$48
Bausch Health US, LLC1$31
Neurocrine BioSciences, Inc.1$29
Takeda Pharmaceuticals U.S.A., Inc.1$29

Products named: CAPLYTA, VRAYLAR, SPRAVATO, REXULTI, FANAPT, ARISTADA, UZEDY, APLENZIN.

Industry payments across VA — which companies pay providers there.